Todd C. Davis, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 34,340 shares at $153.58 ($5.2M) on 2018-02-26, disclosed to the SEC on 2018-02-27.
Open-market sale of $5.2M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $153.58 | 4,835 | $743K | 14.2% |
| 2 | $153.58 | 4,835 | $743K | 14.2% |
| 3 | $151.90 | 12,335 | $1.9M | 35.8% |
| 4 | $151.90 | 12,335 | $1.9M | 35.8% |
| Total | $152.37 avg | 34,340 | $5.2M | 100% |
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |